(INNS)
SEMZUVOLIMAB(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[HOMO SAPIENS CD4 (P55, T CELL SURFACE ANTIGEN T4/LEU-3)], MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN (1-448) [VH MUSMUS/HOMSAP (MUS MUSCULUS IGHV1-75*01 (78.6%) -(IGHD) - IGHJ3*01 (100%)/HOMO SAPIENS IGHV1-2*06 (73.5%) -(IGHD) -IGHJ4*01 (92.3%), CDR-IMGT [8.8.11] (26- 33.51-58.97-107)) (1-118) -HOMO SAPIENS IGHG1*01, G1M17,1, G1V48 H84.4 (CH1 K120 (215) (119-216), HINGE 1-15 (217-231), CH2 N84.4>H (298) (232-341), CH3 D12 (357), L14 (359) (342-446), CHS (447-448)) (119-448)], (221-218')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-218') [V-KAPPA MUSMUS/HOMSAP (MUS MUSCULUS IGKV3-4*01 (93.9%) -IGKJ2*03 (90.9%) S120>Q (104)/HOMO SAPIENS IGKV4-1*01 (68.3%) -IGKJ2*01 (100%), CDR-IMGT [10.3.9] (27-36.54-56.93-101)) (1'- 111') -HOMO SAPIENS IGKC*04 (100%), KM1,2 A45.1 (158), L101 (195) (112'-218')]; DIMER (227-227'':230- 230'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA(WHO)
SEMZUVOLIMABUM(INN)